Bridge to Life Ltd., a top company in organ preservation and perfusion technology, has named David Castiglioni as its Chief Commercial Officer. In this role, Castiglioni will manage all global commercial efforts, with an immediate focus on getting ready for the U.S. launch of the VitaSmart Hypothermic Oxygenated Perfusion System, which is awaiting FDA approval. The U.S. is the biggest market for machine perfusion technology, so this launch is a big deal for the company.
David Castiglioni has over 30 years of experience in healthcare, medtech, and biotech. He has a great background in building strong commercial teams and growing new ventures into international businesses. While at Intuitive Surgical, he helped promote the da Vinci surgical system, which became a market leader under his leadership.
Health Technology Insights: Julius Clinical Welcomes Bassem Saleh as Chief Executive Officer
In recent years, Castiglioni has worked as Chief Commercial Officer at companies like Hyperfine, MediGO (which was acquired by CareDx), and Siren Care. In these roles, he consistently achieved strong revenue growth and created effective go-to-market strategies in regions such as the U.S., Europe, and Asia-Pacific.
Don Webber, President and CEO of Bridge to Life, welcomed Castiglioni to the team, pointing out his excellent track record. Webber said that Castiglioni’s experience in building high-performance commercial teams and his background with innovative products make him the perfect person to lead the U.S. launch of VitaSmart and help drive future growth of Bridge to Life’s transplantation solutions.
Health Technology Insights: AmeriPro Health Elects Larry Richardson as Board Chairman
David Castiglioni expressed excitement about joining Bridge to Life. He mentioned that VitaSmart has already made a big difference in Europe, and the U.S. launch represents a major chance to impact the transplant community. Based on conversations with clinicians, Castiglioni believes VitaSmart has the potential to change transplant care. He is looking forward to developing a commercial strategy and building a team that will bring out the full potential of this groundbreaking technology.
Health Technology Insights: Health Technology Insights: Latest News And Innovations – Roundup 23 September 2025
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
